Communication for the Heartland Regional Genetics Group


Options: Use Forum View

Use Monospaced Font
Show HTML Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Communication for the Heartland Regional Genetics Group <[log in to unmask]>
"Whitehead, Shona R. (HSC)" <[log in to unmask]>
Thu, 22 Sep 2011 15:50:11 -0500
multipart/alternative; boundary="_000_8A2E0C5A8812C7438EA22EAEB16DF60954BF2D5212EXIGEhscnetou_"
Communication for the Heartland Regional Genetics Group <[log in to unmask]>
text/plain (3491 bytes) , text/html (8 kB)

Shona R. Whitehead
Program Coordinator
Heartland Genetics and Newborn Screening Collaborative
405-271-8001 ext. 42190

From: Natasha Bonhomme [mailto:[log in to unmask]]
Sent: Thursday, September 22, 2011 2:58 PM
Subject: Health and Human Services Secretary Adopts New Recommendation on Newborn Screening

September 22, 2011

Contact: Natasha Bonhomme
202-966-5557 x211
[log in to unmask]<mailto:[log in to unmask]>

Health and Human Services Secretary Adopts New Recommendation on Newborn Screening
Recommended Uniform Screening Panel now to include Critical Congenital Heart Disease

WASHINGTON, DC – September 22, 2011 – Health and Human Services Secretary Kathleen Sebelius adopted the recommendation of the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC) that Critical Congenital Heart Disease (CCHD) be included on the Recommended Uniform Screening Panel (RUSP). RUSP is the national recommendation informing states of the congenital conditions that should be included in each state newborn screening program. The SACHDNC put this recommendation forward last year, after following the robust evidence review process they have pioneered. After receiving additional review from the Interagency Coordinating Committee on Screening in Newborns and Children, Secretary Sebelius determined that intervention for this condition during the newborn period is critical to saving lives.

CCHD is a group of heart-related conditions present from birth that cause nearly 3% of infant mortality during the first year of life. Newborn screening for these serious, though often treatable, conditions will include the addition of pulse oximetry screening during the newborn period. Early detection of CCHD, which affects 7 to 9 out of every 1000 live births, allows for critical intervention preventing brain damage, and infant death. This point-of-care screening joins the previously approved blood spot and hearing components of newborn screening.

Genetic Alliance commends Secretary Sebelius’ work and plans to include CCHD in their ongoing newborn screening outreach efforts, through their newborn screening resource Baby’s First Test (www.babyfirsttest.org).

"The process of adding a new condition to the RUSP is a well thought out, rigorous and real, process. Balancing the need for evidence with the urgent needs of the nation’s newborns is critical. We applaud the Secretary’s decision, and look forward to the interagency implementation plan of action", said Natasha Bonhomme, newborn screening director for Genetic Alliance.


About Genetic Alliance
Genetic Alliance transforms health through genetics, promoting an environment of openness centered on the health of individuals, families, and communities. Genetic Alliance brings together diverse stakeholders that create novel partnerships in advocacy; integrates individual, family, and community perspectives to improve health systems; and revolutionizes access to information to enable translation of research into services and individualized decision making. For more information about Genetic Alliance, visit http://www.geneticalliance.org<http://listserv.galists.org/t/611441/172173/15/0/>.

Back to Press Room<press.room>